Deep Dive with George Lazenby on the Pharmacy Podcast Network

written by George Lazenby

Listen to our CEO, George Lazenby, on the Converge podcast, fresh from the NACDS Total Store Expo. Skip ahead to 52:50 to hear his take on industry happenings. Tune in now!


Key Takeaways

  • How you can future-proof your pharmacy for a potential recession

  • How OrderInsite uses the cloud to level the playing field for independent community pharmacies

  • How to prepare for The Drug Supply Chain Security Act (DSCSA) requirement changes in November

  • . . . and more!

“What our tools do is help automate the decisioning around where to purchase, how much to purchase, and when to purchase so you’re always prepared to support the forecasted demand in your pharmacy.”

– George Lazenby

George Lazenby

George Lazenby

Co-Founder/CEO
George Lazenby is the CEO and co-founder of OrderInsite. He is an experienced CEO and Board Member with a demonstrated history of working in the health care industry and skilled in healthcare information technology (HIT), management, sales, executive management, and strategic planning. He was previously CEO of Emdeon (now Change Healthcare).

Related Articles

a man on the phone while checking a box
Why More Data Isn’t the Same as Better Decisions

Pharmacy operations are currently caught in a two-direction squeeze between capital risk and supply disruption. Inventory systems show what is on the shelf, and purchasing tools show what was ordered. …

Read More
Why "Good Enough" DSCSA Compliance is a Risk to Your Pharmacy Operations
Why “Good Enough” DSCSA Compliance is a Risk to Your Pharmacy Operations

The “wait and see” era of the Drug Supply Chain Security Act (DSCSA) has officially ended. For years, the industry relied on stabilization periods and enforcement discretion. Today, the operational …

Read More
Transforming Retail Pharmacies: Embracing Pharmacy Workflow Automation to Combat Pharmacist Burnout

The pandemic shone light on the burdens pharmacists’ face, but if we zoom out, we can understand how COVID was just a milestone on a more than 30-year timeline of industry evolution characterized by historic M&A.

Read More